Founded in 2020, GenCefe Co., Ltd. is headquartered in Wuxi Airport Economic Development Zone, Jiangsu Province, China and started the US branch in 2021. GenCefe focuses on the development and application of molecular biology technologies, using high-throughput, automation technology and artificial intelligence to break through the bottleneck of the gene synthesis industry.

We are aiming to build an innovative synthetic biology technology and application platform, providing integrated CRO services and raw material production to meet the needs of the biomedical industry, in vitro diagnostic industry and scientific research. Our product portfolio serves researchers worldwide in cell and gene therapy, biopharmaceutical and vaccine development, etc. GenCefe's R&D team is led by Prof. Lei Kai, who is an expert of CFPS (Cell Free Protein Synthesis) and a distinguished professor of Jiangsu Province. The company has established an experienced, professional and efficient scientific team, focusing on CRO services and in vitro diagnostic (IVD) reagents core raw materials production.

To comply with ISO9001 quality management standards, GenCefe adopts standardized management operations in the entire process of product development, production, packaging, storage and transportation, as well as company management and operation. We continuously optimize the production and operation procedures to provide high quality products and services to customers.

Company Cultures

Vision：Committed to be a reliable partner for global customers

Mission：Provide customers with the best products and service

Core Values:

Honesty: integrity and keep promises

Teamwork: people-oriented, trustworthy, friendly, happy

Customer first: resolutely safeguard the interests of customers and intellectual property rights Innovation: prioritize both quality and speed, and bring value to the company and customers through innovation